abstract |
The present invention includes treatment of genes spanning a range of genetic disorders with a DHODH inhibitor such as 6-fluoro-2-(2'-fluoro-[1,1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid. Approaches to subtypes of acute myeloid leukemia patients. |